IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.643
EU - Europa 3.811
AS - Asia 2.701
SA - Sud America 822
AF - Africa 141
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 16.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.544
SG - Singapore 1.025
BR - Brasile 704
UA - Ucraina 652
CN - Cina 595
IT - Italia 544
RU - Federazione Russa 464
IE - Irlanda 443
SE - Svezia 399
DE - Germania 394
HK - Hong Kong 319
VN - Vietnam 231
DK - Danimarca 223
GB - Regno Unito 188
TR - Turchia 184
FI - Finlandia 176
FR - Francia 132
KR - Corea 114
CI - Costa d'Avorio 58
IN - India 58
CA - Canada 54
AR - Argentina 50
MA - Marocco 43
PL - Polonia 43
NL - Olanda 41
JP - Giappone 34
ES - Italia 33
BD - Bangladesh 32
ID - Indonesia 32
MX - Messico 32
ZA - Sudafrica 26
BE - Belgio 23
AT - Austria 19
EC - Ecuador 19
IQ - Iraq 19
CO - Colombia 16
PY - Paraguay 13
UZ - Uzbekistan 11
PK - Pakistan 9
LT - Lituania 8
RO - Romania 7
CL - Cile 6
EU - Europa 6
IL - Israele 6
EG - Egitto 5
IR - Iran 5
RS - Serbia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BH - Bahrain 3
JO - Giordania 3
PE - Perù 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GT - Guatemala 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
PW - Palau 1
Totale 16.130
Salva come PNG Salva come JPEG
Città #
Ashburn 858
Chandler 763
Jacksonville 696
Dallas 642
Fairfield 592
Singapore 591
Dublin 442
Des Moines 427
Boardman 390
Hong Kong 317
Woodbridge 277
Wilmington 275
Houston 265
New York 252
Seattle 223
Cambridge 207
Centro 202
Los Angeles 172
The Dalles 163
Lawrence 161
Princeton 160
San Mateo 148
Ann Arbor 124
Beijing 112
Moscow 90
Hefei 83
San Diego 82
Munich 77
Ho Chi Minh City 71
Chicago 63
Buffalo 61
Abidjan 58
Washington 57
São Paulo 55
London 48
Hanoi 47
Turku 41
Guangzhou 36
Warsaw 36
Orem 33
Ancona 31
Shanghai 30
Turin 30
Brooklyn 29
Santa Clara 29
Denver 27
Helsinki 26
Rio de Janeiro 26
Nuremberg 25
Tokyo 24
Wuhan 23
Chennai 21
Johannesburg 20
Montreal 18
Salt Lake City 18
Brussels 17
Norwalk 17
Pune 17
Da Nang 16
Marche 16
Poplar 16
Stockholm 16
Columbus 15
Haiphong 15
Ankara 14
Atlanta 14
Mexico City 14
Wuxi 14
Council Bluffs 13
Salvador 13
Brasília 12
Jiaxing 12
Salamanca 12
Toronto 12
Porto Alegre 11
Tampa 11
Belo Horizonte 10
Elk Grove Village 10
Manchester 10
Torre Annunziata 10
Curitiba 9
Kilburn 9
Ottawa 9
Vienna 9
Baghdad 8
Boston 8
Fayetteville 8
Izmir 8
Milan 8
Perugia 8
Phoenix 8
Rome 8
San Francisco 8
Sterling 8
Tashkent 8
Campinas 7
Falls Church 7
Frankfurt am Main 7
Lahore 7
Ribeirão Preto 7
Totale 10.270
Salva come PNG Salva come JPEG
Nome #
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 188
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 178
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 173
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 163
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 149
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 148
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 148
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 147
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 135
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 135
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 132
Aging and the Biological Response to Liver Injury 132
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 132
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 131
Hepatitis E in a region of Italy: An emerging autochthonous infection? 129
Descriptive epidemiology of cholangiocarcinoma in Italy. 128
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 127
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 127
Cholangiocarcinoma development: the resurgence of bile acids 125
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 125
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 124
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 124
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 124
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 123
Clinical implications of novel aspects of biliary pathophysiology. 122
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 122
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 122
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 121
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 121
Leptin enhances cholangiocarcinoma cell growth. 121
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 121
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 120
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 119
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 119
Functional and Structural Features of Cholangiocytes in Health and Disease 116
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 115
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 114
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 114
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 114
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 113
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 112
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 112
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 112
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 111
Current targets for Primary Sclerosing cholangitis 111
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 110
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 110
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 109
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 109
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 108
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 108
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 107
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 106
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 106
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 104
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 103
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 103
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 102
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 100
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 98
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 98
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 98
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 98
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 98
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 97
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 97
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 97
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 96
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 96
Glucagon-like Peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis 96
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 96
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 96
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 95
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 95
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 94
Functional heterogeneity of the intrahepatic biliary tree 93
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 92
Role of apoptosis in development of primary biliary cirrhosis 92
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 91
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 91
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 90
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 89
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 89
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 89
Development and functional characterization of extrahepatic cholangiocyte lines from normal rats 89
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 87
Role of cholangiocytes in primary biliary cirrhosis 87
Primary Biliary Cholangitis: advances in management and treatment of the disease 87
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 86
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 86
NUOVA METODICA DIAGNOSTICA PER LE NEOPLASIE DEL PANCREAS 85
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 85
Heterogeneity of the Intrahepatic Biliary Epithelium 84
The significance of genetics for cholangiocarcinoma development 84
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 84
Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma 83
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 83
Involvement of autophagy in ageing and chronic cholestatic diseases 83
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy 83
Small Mouse cholangiocytes proliferate in response to H1 Histamine receptor stimulation by activation of the IP3/CAMK I/CREB pathway. 81
Totale 11.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.332 0 0 0 0 0 141 183 188 205 242 226 147
2021/20221.351 71 341 19 36 14 68 79 83 67 98 219 256
2022/20232.495 212 202 140 188 154 616 4 160 600 13 159 47
2023/20241.519 246 33 118 302 241 326 16 29 11 27 10 160
2024/20252.771 317 277 103 45 82 115 159 96 702 206 282 387
2025/20263.993 501 450 695 1.099 842 406 0 0 0 0 0 0
Totale 16.581